What is Suspicious Order Monitoring?
DEA 21 CFR 1301.74b

The DEA 21 CFR 1301.74 b mandate describes suspicious orders as having significant deviation in:

• Order Size (Quantity)
• Order Frequency
• Order Pattern

Anti-diversion is Proactive, not Reactive:
Controlled Substance Registrants are required to place on hold, investigate, and disclose to the DEA all suspicious ORDERS of controlled sustances; NOT suspicious SALES after the fact.

“Using a computer to manage and report on high volume transaction business activities with extremely short order cycle times (receipt to delivery) is the only viable, cost effective methodology for the reporting of orders which may be considered excessive or suspicious.” -DEA

Who Must Comply with DEA 21 CFR 1301.74b?

The SOMLink™ Solution

SOMLink Demonstration

Features and Benefits Overview